Advertisement

Cambridge-based vaccine developer Variation Biotechnologies Inc. has raised a combined $7.8 million in a pair of debt financings, according to federal documents filed yesterday.

One funding was for $3.5 million in debt and options or warrants for securities, and the second was for $4.3 million in the same categories. The filings with the U.S. Securities and Exchange Commission did not disclose the names of the four backing entities in each funding, but Variation has been backed by Clarus Ventures LLC, Arch Venture Partners and 5AM Ventures.

SOURCE

Advertisement
Advertisement